In this presentation Whitney Essex, APRN-CNP shares on prevention, monitoring, and treating infectious diseases in the setting of pharmacotherapy for substance use disorders. She discusses infectious diseases associated with substance use… […]
Keyword: mat
Language of Addiction | October 19, 2022
Dr. Karla Thornton, Professor of Infectious Diseases at the University of New Mexico Health Sciences Center, speaks about the importance of using non-stigmatizing language in substance use and shares the… […]
Starting and Expanding MAT Programs | October 25, 2022
In this discussion, Dr. Ashely Quanbeck, MD, and Dr. Bradley Moran, PharmD, share on their efforts and lessons learned in starting Medications for Opioid Use Disorder Programs (MOUD). Dr. Moran… […]
Read More… from Starting and Expanding MAT Programs | October 25, 2022
Harm Reduction, SSPs, and Me | May 5, 2022
In this presentation, Jessica Rienstra, RN, BSN, discusses the goals of Harm Reduction and how it is used throughout healthcare and in our daily lives. She also discusses the cost… […]
Microdose Buprenorphine Induction | April 7, 2022
In this presentation, Dr. Jonathan Robbins, MD, defines buprenorphine microdosing and several protocols for microinduction. Additionally, case studies from both inpatient and outpatient settings are reviewed as well as guidelines… […]
Read More… from Microdose Buprenorphine Induction | April 7, 2022
MAT and the HCV Provider | March 23, 2022
In this presentation Dr. Jessica Gregg provides an overview of screening, treatment options, and individualized care for patients with substance use disorder and hepatitis C virus. The trifecta of interventions… […]
Sample CPA (BOP)
Sample Collaborative Practice Agreement (CPA) for Pharmacy Delivered Patient Care Services, including Diabetes, Hepatitis C, and Medication-Assisted Treatment within the Federal Bureau of Prisons (BOP) […]
Integrated MAT Perspectives | May 18, 2021
In this presentation, LCDR Kristin Allmaras discusses integrated MAT perspectives. […]
HCV and People Who Inject Drugs | HCV and SUD Treatment | May 4, 2021
In this series of presentations, Jessica Gregg, MD, shares information on HCV in people who inject drugs, and medications used to treat opioid use disorder. Then, Melissa McFarland, MSN, FNP-BC, shares how… […]
Read More… from HCV and People Who Inject Drugs | HCV and SUD Treatment | May 4, 2021
Substance Use Disorder | April 15, 2021
Dependence on opiates such as painkillers and heroin continue to cause overdose and trauma to families across Indian Country. There is no perfect solution, but approaches such as Harm Reduction… […]